Literature DB >> 16730430

The five-factor model of the Positive and Negative Syndrome Scale I: confirmatory factor analysis fails to confirm 25 published five-factor solutions.

Mark van der Gaag1, Anke Cuijpers, Tonko Hoffman, Mila Remijsen, Ron Hijman, Lieuwe de Haan, Berno van Meijel, Peter N van Harten, Lucia Valmaggia, Marc de Hert, Durk Wiersma.   

Abstract

OBJECTIVE: The aim of this study was to test the goodness-of-fit of all previously published five-factor models of the Positive and Negative Syndrome Scale (PANSS).
METHODS: We used confirmatory factor analysis (CFA) with a large data set (N = 5769).
RESULTS: The different subsamples were tested for heterogeneity and were found to be homogeneous. This indicates that despite variability in age, sex, duration of illness, admission status, etc., in the different subsamples, the structure of symptoms is the same for all patients with schizophrenia. Although previous research has shown that a five-factor model fits the data better than models with three or four factors, no satisfactory fit for any of the 25 published five-factor models was found with CFA.
CONCLUSIONS: Variability in age, sex, admission status and duration of illness has no substantial effect on the structure of symptoms in schizophrenia. The lack of fit can be caused by ill-defined items that aim to measure several properties in a single rating. Another explanation is that well-defined symptoms can have two or more causes. Then a double or triple loading item should not be discarded, but included because the complexity of symptoms in schizophrenia is represented by these multiple loadings. Such a complex model not only needs confirmation by CFA, but also has to be proven stable. A 10-fold cross-validation is suggested to develop a complex and stable model.

Entities:  

Mesh:

Year:  2006        PMID: 16730430     DOI: 10.1016/j.schres.2006.04.001

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  48 in total

1.  Genetic Risk and Outcome of Psychosis (GROUP), a multi-site longitudinal cohort study focused on gene-environment interaction: objectives, sample characteristics, recruitment and assessment methods.

Authors:  Nikie Korver; Piotr J Quee; Heleen B M Boos; Claudia J P Simons; Lieuwe de Haan
Journal:  Int J Methods Psychiatr Res       Date:  2012-03-15       Impact factor: 4.035

Review 2.  Progress in defining optimal treatment outcome in schizophrenia.

Authors:  Gary Remington; George Foussias; Ofer Agid
Journal:  CNS Drugs       Date:  2010-01       Impact factor: 5.749

3.  Sparse factors for the positive and negative syndrome scale: which symptoms and stage of illness?

Authors:  Ariana Anderson; Marsha Wilcox; Adam Savitz; Hearee Chung; Qingqin Li; Giacomo Salvadore; Dai Wang; Isaac Nuamah; Steven P Riese; Robert M Bilder
Journal:  Psychiatry Res       Date:  2015-01-06       Impact factor: 3.222

4.  Bifactor Modeling of the Positive and Negative Syndrome Scale: Generalized Psychosis Spans Schizoaffective, Bipolar, and Schizophrenia Diagnoses.

Authors:  Ariana E Anderson; Stephen Marder; Steven P Reise; Adam Savitz; Giacomo Salvadore; Dong Jing Fu; Qingqin Li; Ibrahim Turkoz; Carol Han; Robert M Bilder
Journal:  Schizophr Bull       Date:  2018-10-17       Impact factor: 9.306

5.  Distinct Patterns of Cerebral Cortical Thinning in Schizophrenia: A Neuroimaging Data-Driven Approach.

Authors:  Genichi Sugihara; Naoya Oishi; Shuraku Son; Manabu Kubota; Hidehiko Takahashi; Toshiya Murai
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

Review 6.  Are Shorter Versions of the Positive and Negative Syndrome Scale (PANSS) Doable? A Critical Review.

Authors:  Jean-Pierre Lindenmayer
Journal:  Innov Clin Neurosci       Date:  2017-12-01

Review 7.  Positive and Negative Syndrome Scale (PANSS) Training: Challenges, Solutions, and Future Directions.

Authors:  Mark G A Opler; Christian Yavorsky; David G Daniel
Journal:  Innov Clin Neurosci       Date:  2017-12-01

8.  The impact of immigration and visible minority status on psychosis symptom profile.

Authors:  Akiah Ottesen Berg; Ole A Andreassen; Sofie Ragnhild Aminoff; Kristin Lie Romm; Edvard Hauff; Ingrid Melle
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-06-14       Impact factor: 4.328

9.  Personality compensates for impaired quality of life and social functioning in patients with psychotic disorders who experienced traumatic events.

Authors:  Lindy-Lou Boyette; Daniëlla van Dam; Carin Meijer; Eva Velthorst; Wiepke Cahn; Lieuwe de Haan; René Kahn; Lieuwe de Haan; Jim van Os; Durk Wiersma; Richard Bruggeman; Wiepke Cahn; Carin Meijer; Inez Myin-Germeys
Journal:  Schizophr Bull       Date:  2014-04-25       Impact factor: 9.306

10.  Improvements in negative symptoms and functional outcome after a new generation cognitive remediation program: a randomized controlled trial.

Authors:  Pedro Sánchez; Javier Peña; Eneritz Bengoetxea; Natalia Ojeda; Edorta Elizagárate; Jesus Ezcurra; Miguel Gutiérrez
Journal:  Schizophr Bull       Date:  2013-05-18       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.